Instituto Mexicano del Seguro Social
🇲🇽Mexico
- Country
- 🇲🇽Mexico
- Ownership
- Private
- Established
- 1943-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.imss.gob.mx
Clinical Trials
113
Active:6
Completed:78
Trial Phases
6 Phases
Early Phase 1:1
Phase 1:4
Phase 2:5
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (83 trials with phase data)• Click on a phase to view related trials
Not Applicable
44 (53.0%)Phase 3
19 (22.9%)Phase 4
10 (12.0%)Phase 2
5 (6.0%)Phase 1
4 (4.8%)Early Phase 1
1 (1.2%)DOR/TDF/3TC COmpared With BIC/FTC/TAF in ART-Naïve People Living With HIV and Overweight or Obesity
Not Applicable
Recruiting
- Conditions
- HIV - Human Immunodeficiency VirusObesityOverweight and/or Obesity
- Interventions
- Drug: DOR/3TC/TDF
- First Posted Date
- 2025-07-20
- Last Posted Date
- 2025-07-20
- Lead Sponsor
- Instituto Mexicano del Seguro Social
- Target Recruit Count
- 306
- Registration Number
- NCT07075146
- Locations
- 🇲🇽
Hospital de infectología, Centro Médico Nacional La Raza, Mexico City, Mexico
Effect of Lidocaine-Dexmedetomidine on Pain, Inflammation, and Oxidative Stress After Bariatric Surgery.
Not Applicable
Not yet recruiting
- Conditions
- Postoperative Adjuvant TreatmentMorbid Obesity Requiring Bariatric SurgeryPostoperative AnalgesiaPostoperative PainPostoperative Pain ManagementPostoperative Inflammatory MarkersPostoperative Inflammatory Response
- Interventions
- Drug: Intravenous Lidocaine infusion + Standard AnesthesiaDrug: Intravenous Dexmedetomidine infusion + Standard AnesthesiaDrug: Lidocaine + Dexmedetomidine Combination (LIDEX) + Standard AnesthesiaDrug: 0.9 % Saline Placebo + Standard Anesthesia
- First Posted Date
- 2025-07-18
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Instituto Mexicano del Seguro Social
- Target Recruit Count
- 104
- Registration Number
- NCT07073846
- Locations
- 🇲🇽
Unidad Médica de Alta Especialidad Hospital de Especialidades del Centro Médico Nacional Siglo XXI, Mexico City, Mexico
Subciliary Closure in Orbital Fracture
Not Applicable
Completed
- Conditions
- Orbital Floor FracturesSurgical Wound Closure TechniquesSubciliary Surgical ApproachPostoperative Complications in Maxillofacial Surgery
- First Posted Date
- 2025-06-29
- Last Posted Date
- 2025-07-04
- Lead Sponsor
- Instituto Mexicano del Seguro Social
- Target Recruit Count
- 100
- Registration Number
- NCT07042763
- Locations
- 🇲🇽
Hospital de Especialidades del Centro Médico Nacional de Occidente (CMNO) - IMSS, Guadalajara, Jalisco, Mexico
Safety, Tolerability and Effectiveness of DTG/3TC vs BIC/TAF/FTC in PWH Without Antiretroviral Experience
Phase 4
Recruiting
- Conditions
- HIV InfectionMetabolic SyndromeAntiretroviral Treatment
- Interventions
- First Posted Date
- 2025-06-22
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- Instituto Mexicano del Seguro Social
- Target Recruit Count
- 124
- Registration Number
- NCT07031063
- Locations
- 🇲🇽
Hospital de infectología, Centro Médico Nacional La Raza, Mexico city, Azcapotzalco, Mexico
Autologous Fat Infiltration Versus General Measures as Treatment in Radiodermatitis Induced for Radiotherapy in Breast Cancer Patients
Not Applicable
Completed
- Conditions
- Breast CancerRadio DermatitisRadiotherapy
- First Posted Date
- 2025-06-17
- Last Posted Date
- 2025-06-17
- Lead Sponsor
- Instituto Mexicano del Seguro Social
- Target Recruit Count
- 22
- Registration Number
- NCT07023796
- Locations
- 🇲🇽
Belisario Dominguez 1000, Guadalajara, Jalisco, Mexico
- Prev
- 1
- 2
- 3
- 4
- 5
- 23
- Next
News
No news found